PMN
Price:
$7.63
Market Cap:
$9.98M
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; ...[Read more]
Industry
Biotechnology
IPO Date
2007-01-10
Stock Exchange
NASDAQ
Ticker
PMN
According to ProMIS Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.76. This represents a change of -51.90% compared to the average of 3.65 of the last 4 quarters.
The mean historical Current Ratio of ProMIS Neurosciences, Inc. over the last ten years is 3.97. The current 1.76 Current Ratio has changed 4.32% with respect to the historical average. Over the past ten years (40 quarters), PMN's Current Ratio was at its highest in in the December 2021 quarter at 19.07. The Current Ratio was at its lowest in in the June 2023 quarter at 0.17.
Average
3.97
Median
1.53
Minimum
0.52
Maximum
19.07
Discovering the peaks and valleys of ProMIS Neurosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.59%
Maximum Annual Current Ratio = 19.07
Minimum Annual Increase = -94.35%
Minimum Annual Current Ratio = 0.52
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 8.52 | 485.23% |
| 2023 | 1.46 | 35.32% |
| 2022 | 1.08 | -94.35% |
| 2021 | 19.07 | 3.59% |
| 2020 | 0.52 | -57.25% |
| 2019 | 1.21 | -24.80% |
| 2018 | 1.61 | -51.37% |
| 2017 | 3.31 | 230.86% |
| 2016 | 1.00 | -48.76% |
| 2015 | 1.95 | 366.44% |
The current Current Ratio of ProMIS Neurosciences, Inc. (PMN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.69
5-year avg
6.13
10-year avg
3.97
ProMIS Neurosciences, Inc.’s Current Ratio is less than MapLight Therapeutics, Inc. (0), greater than Ernexa Therapeutics Inc. (1.58), greater than OSR Holdings, Inc. (0.21), less than Lipocine Inc. (12.71), greater than Adaptimmune Therapeutics plc (1.52), less than Edesa Biotech, Inc. (18.97), greater than Adlai Nortye Ltd. (1.41), less than GeoVax Labs, Inc. (3.57), greater than Tharimmune, Inc. (1.17), less than BioRestorative Therapies, Inc. (2.07),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0 | $14.48M | |
| 1.58 | $10.28M | |
| 0.21 | $17.76M | |
| 12.71 | $16.63M | |
| 1.52 | $75.16M | |
| 18.97 | $11.89M | |
| 1.41 | $37.48M | |
| 3.57 | $9.73M | |
| 1.17 | $86.56M | |
| 2.07 | $9.46M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProMIS Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProMIS Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ProMIS Neurosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for ProMIS Neurosciences, Inc. (PMN)?
What is the highest Current Ratio for ProMIS Neurosciences, Inc. (PMN)?
What is the 3-year average Current Ratio for ProMIS Neurosciences, Inc. (PMN)?
What is the 5-year average Current Ratio for ProMIS Neurosciences, Inc. (PMN)?
How does the current Current Ratio for ProMIS Neurosciences, Inc. (PMN) compare to its historical average?